Bioequivalence Studies of Dasatinib 100 mg
Condition(s):Myeloma MultipleLast Updated:July 13, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Myeloma MultipleLast Updated:July 13, 2023Not yet recruiting
Condition(s):Lymphoblastic LeukemiaLast Updated:February 8, 2024Recruiting
Condition(s):Waldenstrom Macroglobulinemia; DASATINIBLast Updated:March 21, 2024Terminated
Condition(s):Ph Positive ALL; CAR-T Cell; DasatinibLast Updated:November 28, 2023Recruiting
Condition(s):Dasatinib; BCR-ABL; Chronic Myeloid LeukemiaLast Updated:July 27, 2022Recruiting
Condition(s):Chronic Myelogenous LeukemiaLast Updated:July 13, 2017Unknown status
Condition(s):Schizophrenia; Treatment Resistant Depression; Aging, PrematureLast Updated:September 5, 2023Recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 29, 2023Active, not recruiting
Condition(s):Pharmacokinetics; Drug InteractionsLast Updated:June 27, 2022Completed
Condition(s):Drug-drug Interaction StudyLast Updated:November 24, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.